Treatment of Depression Using Medication Research Paper by scribbler

An examination of the treatment of depression, including the use of selective serotonin reuptake inhibitors (SSRIs) and other treatments.
# 152386 | 2,804 words | 10 sources | APA | 2013 | US
Published on Feb 04, 2013 in Psychology (Disorders) , Medical and Health (Drugs) , Medical and Health (Pharmacy)

$19.95 Buy and instantly download this paper now


This paper explores pharmacotherapy in primary care and looks at the efficacy of escitalopram and specifically, escitalopram in adolescents. Next, the paper discusses
duloxetine as a treatment of depression, the expected relapse during treatment with SSRIs, the non-acceptance of SSRIs and misleading advertisements on SSRIs. Finally, the paper looks at deep brain stimulation as a treatment option, yoga as a complementary and alternative treatment, and at current strategies in treating chronic depression.

Pharmacotherapy in Primary Care
Efficacy of Escitalopram
Escitalopram in Adolescents
Duloxetine as Treatment of MDD
Relapse during Treatment with SSRIs
Non-Acceptance of SSRIs
Misleading Advertisements on SSRIs
Deep Brain Stimulation as Treatment Option
Yoga as Complementary and Alternative Treatment
Current Strategies in Treating Chronic Depression

From the Paper:

"The large overall burden imposed by the disability and lost productivity and the resulting financial strain on health care necessitates the use of the most efficient and cost-efficient treatment. The precise approach to major depressive disorder or MDD and anxiety disorders is sustained remission and the prevention of relapse (Lam & Annemans, 2007 p 559). Patients with remission have better prognosis, function and more stable condition than those without remission. Remission is a maintained period of minimal symptoms. Achieving remission also entails significantly less healthcare costs and improved quality of life (Lam & Annemans pp 560-562).
"Selective serotonin reuptake inhibitors or SSRIs and serotonin norepinephrine reuptake inhibitors or SNRIs antidepressants are considered first-line therapy for MDD and anxiety disorders (Lam & Annemans, 2007 p 562). Escitalopram has been the favored SSRI for the two disorders and panic disorders. The dose is 10-20 mg a day for treatment of depression. Compared with other antidepressants, escitalopram proved to be or equal or superior efficacy, according to clinical trials. Acquisition costs are higher than for generic drugs, like fluoxetine and citalopram. But several economic studies showed that direct and indirect costs of treatment are lower with the use of escitalopram than other antidepressants. It has superior ability to improve remission rates and realize more savings than other treatments."

Sample of Sources Used:

  • Abosch, A. and Cosgrove, R (2008). Biological basis for the surgical treatment of depression. Neurosurgical Focus, 25 (1). Retrieved on May 8, 2010 from
  • Barclay, L (2005). Advertisements for SSRIs may be misleading. Public Library of Science Medicine, 2 (12). Retrieved on May 8, 2010 from
  • Buck, M. L. (2009). Escitalopram for the treatment of depression in adolescents. Pediatric Pharmacotherapy, 15 (9). Retrieved on May 8, 2010 from
  • Goldbert J. F.(2002). The treatment of chronic depression: current strategies and future directions. Psychiatry & Mental Health eJournal, 2 (3). Retrieved on May8, 2010 from
  • Goldberg, J. and Kocsis, J. H. (2002). Relapse during SSRI treatment for depression.Medscape Psychiatry & Mental Health, 1 (5). Retrieved on May 8, 2010 from

Cite this Research Paper:

APA Format

Treatment of Depression Using Medication (2013, February 04) Retrieved March 31, 2023, from

MLA Format

"Treatment of Depression Using Medication" 04 February 2013. Web. 31 March. 2023. <>